本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

94.86
-0.2100-0.22%
盘后96.001.14+1.20%19:52 EDT
成交量:146.56万
成交额:1.41亿
市值:187.99亿
市盈率:-15.94
高:99.09
开:96.44
低:94.67
收:95.07
52周最高:124.49
52周最低:29.17
股本:1.98亿
流通股本:1.79亿
量比:0.75
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-5.9502
净资产收益率:-58.07%
总资产收益率:-30.08%
市净率:11.52
市盈率(LYR):-15.94

数据加载中...

2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities